This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Journey of Michael Vance Milburn
Introduction
Michael Vance Milburn is an accomplished inventor based in Morrisville, North Carolina. He has made significant contributions to the field of pharmacology with a focus on the design of novel antagonists for key receptors involved in various biological processes. His work exemplifies the fusion of creativity and scientific rigor in the advancement of medical therapies.
Latest Patents
Milburn holds a pivotal patent for an "Oxazole PPAR antagonist." This patent discloses a method for the rational design of antagonists for PPAR, FXR, LXR-alpha, or LXR-beta. The method centers on the chemical modification of already existing agonists to achieve antagonism by preventing hydrogen bonding with crucial amino acids like tyrosine, histidine, or tryptophan, which are vital for receptor activation. Notably, this innovative approach aims to produce structural analogues of the agonists with minimal changes, enhancing potential therapeutic applications.
Career Highlights
Michael Vance Milburn is currently affiliated with SmithKline Beecham Corporation, where he continues to advance the field of drug development and molecular design. His commitment to innovation is evident through his single yet impactful patent, which showcases his ability to blend scientific insight with practical application.
Collaborations
Throughout his career, Milburn has worked alongside esteemed colleagues such as Jeffrey Edmond Cobb and Millard Hurst Lambert, III. These collaborations have undoubtedly enriched his research endeavors, fostering an environment of shared knowledge and collective problem-solving in the pursuit of new therapies.
Conclusion
In conclusion, Michael Vance Milburn's innovative approach to the rational design of PPAR antagonists reinforces his status as a significant contributor to the field of medicinal chemistry. His patented work has the potential to inspire future research and developments in pharmacology, paving the way for novel treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile